Product Information
- rel-6,7-Dimethyl (1R,5R,6R,7S)-4-oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate
- 8-Azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid, 4-oxo-8-(phenylmethyl)-, 6,7-dimethyl ester, (1R,5R,6R,7S)-rel-
SD 1008 is a histone lysine modulator that has been shown to improve memory in animal models of Alzheimer's disease. It works by binding to the active site of the enzyme acetylcholinesterase, which breaks down the brain chemical acetylcholine. SD 1008 also reduces virus-induced cell degranulation and synapses in mouse brains. It is a conjugate of pyridine compounds with polymer chains that signal transducers and are targeted for cancer therapy. The structure of SD 1008 is similar to other drug molecules that have been developed for cancer treatment, including drugs targeting integrin receptors. This similarity may be useful when treating cancers that express this receptor as it may help reduce side effects caused by these drugs.
Chemical properties
Technical inquiry about: 3D-KNB20181 SD 1008
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
